- Home
- SIM vs ALKS Comparison
SIM vs ALKS Comparison
Compare SIM & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIM
- ALKS
- Stock Information
- Founded
- SIM 1969
- ALKS 1987
- Country
- SIM Mexico
- ALKS Ireland
- Employees
- SIM N/A
- ALKS N/A
- Industry
- SIM Steel/Iron Ore
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- SIM Industrials
- ALKS Health Care
- Exchange
- SIM Nasdaq
- ALKS Nasdaq
- Market Cap
- SIM 3.8B
- ALKS 4.5B
- IPO Year
- SIM 1993
- ALKS 1991
- Fundamental
- Price
- SIM $28.00
- ALKS $27.84
- Analyst Decision
- SIM
- ALKS Buy
- Analyst Count
- SIM 0
- ALKS 12
- Target Price
- SIM N/A
- ALKS $38.55
- AVG Volume (30 Days)
- SIM 712.0
- ALKS 1.9M
- Earning Date
- SIM 05-06-2025
- ALKS 05-01-2025
- Dividend Yield
- SIM N/A
- ALKS N/A
- EPS Growth
- SIM 148.61
- ALKS 3.47
- EPS
- SIM 3.32
- ALKS 2.17
- Revenue
- SIM $1,615,252,951.00
- ALKS $1,557,632,000.00
- Revenue This Year
- SIM N/A
- ALKS N/A
- Revenue Next Year
- SIM N/A
- ALKS $4.09
- P/E Ratio
- SIM $8.43
- ALKS $12.83
- Revenue Growth
- SIM N/A
- ALKS N/A
- 52 Week Low
- SIM $22.15
- ALKS $22.90
- 52 Week High
- SIM $33.78
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- SIM 62.65
- ALKS 36.32
- Support Level
- SIM $24.00
- ALKS $26.70
- Resistance Level
- SIM $27.32
- ALKS $27.95
- Average True Range (ATR)
- SIM 0.53
- ALKS 1.25
- MACD
- SIM 0.15
- ALKS 0.06
- Stochastic Oscillator
- SIM 100.00
- ALKS 46.82
About SIM Grupo Simec S.A.B. de C.V.
Grupo Simec SAB de CV is a diversified manufacturer, processor, and distributor of SBQ steel and structural steel products with production and commercial operations. The group's SBQ products are used across a range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. Its structural steel products are used in the non-residential construction market and other construction applications. Its segments are Mexico, Brazil, and the United States.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.